Pathogenic variants in actionable MODY genes are associated with type 2 diabetes (2020)

First Author: Bonnefond A
Attributed to:  Targeting GLP-1 receptor trafficking to improve therapies for type 2 diabetes funded by MRC

Abstract

No abstract provided

Bibliographic Information

Digital Object Identifier: http://dx.doi.org/10.1038/s42255-020-00294-3

Publication URI: http://dx.doi.org/10.1038/s42255-020-00294-3

Type: Journal Article/Review

Parent Publication: Nature Metabolism

Issue: 10